Eric J. Bow
Impact in
- Clinical Biochemistry top 0.05%
- Bacterial Identification and Susceptibility Testing
- Oncology top 0.2%
- Neutropenia and Cancer Infections
Papers in
- Oncology 49
- Neutropenia and Cancer Infections 48
- Epidemiology 42
- Fungal Infections and Studies 27
- Pneumocystis jirovecii pneumonia detection and treatment 10
- Mycobacterium research and diagnosis 5
- Co-authors
- Kenneth V. I. Rolston (7 shared papers)John R. Wingard (4 shared papers)Michael Boeckh (2 shared papers)Jo‐Anne H. Young (3 shared papers)Alison G. Freifeld (2 shared papers)Kent A. Sepkowitz (2 shared papers)Issam Raad (3 shared papers)James I. Ito (2 shared papers)
- Journals
- Clinical Infectious Diseases (10 papers)Journal of Clinical Oncology (6 papers)Cancer (3 papers)The American Journal of Medicine (3 papers)Seminars in Hematology (2 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Eric J. Bow
75 papers receiving 8.1k citations
Eric J. Bow's Hit Papers
Peers
Comparison fields: 5 of 120
- Clinical Biochemistry 2.2k
- Oncology 5.3k
- Infectious Diseases 3.1k
- Applied Microbiology and Biotechnology 217
- Epidemiology 3.7k
Countries citing papers authored by Eric J. Bow
This map shows the geographic impact of Eric J. Bow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric J. Bow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric J. Bow more than expected).
Fields of papers citing papers by Eric J. Bow
This network shows the impact of papers produced by Eric J. Bow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric J. Bow. The network helps show where Eric J. Bow may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric J. Bow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2011 | 2328 |
| 2 | 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer Hit paper breakdown → | 2002 | 1426 |
| 3 | Executive Summary: Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America Hit paper breakdown → | 2011 | 507 |
| 4 | 1998 | 461 | |
| 5 | Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update Hit paper breakdown → | 2018 | 356 |
| 6 | Combination Antifungal Therapy for Invasive Aspergillosis Hit paper breakdown → | 2015 | 333 |
| 7 | 2013 | 305 | |
| 8 | 2018 | 211 | |
| 9 | 1999 | 200 | |
| 10 | 2002 | 188 | |
| 11 | 1991 | 170 | |
| 12 | 1995 | 145 | |
| 13 | 1999 | 107 | |
| 14 | 2011 | 91 | |
| 15 | 1988 | 88 | |
| 16 | 2006 | 87 | |
| 17 | 2010 | 79 | |
| 18 | 1997 | 78 | |
| 19 | Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study. | 1987 | 60 |
| 20 | 2014 | 57 |
About Eric J. Bow
Eric J. Bow is a scholar working on Oncology, Epidemiology, Infectious Diseases, Clinical Biochemistry and Hematology, having authored 75 papers that have together received 8.3k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (48 papers), Antifungal resistance and susceptibility (30 papers), Fungal Infections and Studies (27 papers), Bacterial Identification and Susceptibility Testing (14 papers), Pneumocystis jirovecii pneumonia detection and treatment (10 papers), Acute Myeloid Leukemia Research (6 papers), Hematological disorders and diagnostics (6 papers) and Mycobacterium research and diagnosis (5 papers). The work is most often cited by research in Clinical Biochemistry (2.2k citations), Oncology (5.3k citations), Infectious Diseases (3.1k citations), Applied Microbiology and Biotechnology (217 citations) and Epidemiology (3.7k citations). Eric J. Bow has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Kenneth V. I. Rolston, John R. Wingard, Michael Boeckh, Jo‐Anne H. Young, Alison G. Freifeld, Kent A. Sepkowitz, Issam Raad, James I. Ito, Craig A. Mullen and Lowell S. Young. Their work appears in journals such as Clinical Infectious Diseases, Journal of Clinical Oncology, Cancer, The American Journal of Medicine and Seminars in Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.